文献速递物质与行为成瘾心境障碍焦虑、强迫与应激相关障碍

世界卫生组织风险饮酒水平测量:2001-2002与2012-2013年美国成人全国代表性调查中的患病率与健康关联

The World Health Organization Risk Drinking Levels Measure of Alcohol Consumption: Prevalence and Health Correlates in Nationally Representative Surveys of U.S. Adults, 2001-2002 and 2012-2013.
PubMed 文献 · Am J Psychiatry · 2021-01-21

该研究分析2001-2002年NESARC(N=26,655)和2012-2013年NESARC-III(N=25,659)当前饮酒者数据,用逻辑回归估计WHO风险饮酒水平(极高、高、中、低)的患病率变化及与健康条件的关联。2012-2013年中、高、极高风险饮酒患病率分别为5.9%、3.2%、3.5%,较2001-2002年的1.0%、0.6%、0.9%显著增加;极高风险饮酒增加在男性(0.5%)小于女性(1.4%)。两调查中健康条件与极高、高、中风险饮酒显著相关,关联性别相似但男性AUD更强、女性功能损害及抑郁焦虑障碍更强。

要点

  • 2012-2013年中、高、极高风险饮酒患病率较2001-2002年显著增加。
  • 极高风险饮酒增加在女性(1.4%)大于男性(0.5%)。
  • 健康条件与极高、高、中风险饮酒显著相关,支持WHO风险饮酒水平的临床效用。

核心结论

  • 美国成人潜在问题饮酒水平增加,强调需要更好的预防和治疗策略。
  • 研究结果支持WHO风险饮酒水平的有效性,其作为非戒断饮酒减少治疗目标具有临床效用。

研究设计与样本

  • 分析2001-2002年NESARC(N=26,655)和2012-2013年NESARC-III(N=25,659)当前饮酒者数据,使用逻辑回归。
  • 估计各饮酒水平总体及按性别的调查间患病率差异,并在各调查内估计健康条件与WHO风险饮酒水平的患病率差异。

主要发现

  • 2012-2013年中、高、极高风险饮酒患病率分别为5.9%、3.2%、3.5%,显著高于2001-2002年的1.0%、0.6%、0.9%。
  • 极高风险饮酒增加在男性为0.5%,女性为1.4%。
  • 两调查中,与低风险相比,健康条件与极高风险(患病率差异范围2.2%-57.8%)、高风险(2.6%-41.3%)、中风险(0.6%-29.8%)饮酒显著相关。
  • 关联性别相似,但男性AUD效应更强,女性功能损害及抑郁焦虑障碍效应更强。

关键数值与推荐

  • WHO风险饮酒水平分为极高、高、中、低四类。
  • 健康条件包括酒精使用障碍(AUD)、药物使用障碍、功能损害、肝病、抑郁和焦虑障碍。

临床怎么用

  • WHO风险饮酒水平可作为非戒断饮酒减少治疗目标,可能吸引更多人参与治疗。
  • 临床应关注女性极高风险饮酒增加趋势及男性AUD、女性功能损害及抑郁焦虑障碍的更强关联。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Little is known about change over time in the prevalence of World Health Organization (WHO) risk drinking levels (very high, high, moderate, low) and their association with health conditions, overall and by gender. The authors used two sets of nationally representative U.S. survey data to determine whether changes over time varied by gender and to examine whether health conditions related to alcohol were associated with WHO risk drinking level within each survey, and whether these associations differed by gender. METHODS: Data on current drinkers from the 2001-2002 National Epidemiologic Survey on Alcohol and Related Conditions (NESARC; N=26,655) and the 2012-2013 NESARC-III (N=25,659) were analyzed using logistic regression. Prevalence differences between surveys were estimated for each drinking level overall and by gender. Within each survey, prevalence differences by WHO risk drinking level were estimated for alcohol use disorder (AUD), drug use disorders, functional impairment, liver disease, and depressive and anxiety disorders. RESULTS: In the 2012-2013 survey, the prevalences of moderate, high, and very high risk drinking were 5.9%, 3.2%, and 3.5%, respectively, representing significant increases from the prevalences in the 2001-2002 survey, which were 1.0%, 0.6%, and 0.9%, respectively. The increase for very high risk drinking among men (0.5%) was smaller than the increase among women (1.4%). Within both surveys, compared with low risk, health conditions were significantly associated with very high risk (range of prevalence differences, 2.2%-57.8%), high risk (2.6%-41.3%), and moderate risk (0.6%-29.8%) drinking. Associations were similar by gender, except that there were stronger effects for AUD in men and for functional impairment and depressive and anxiety disorders in women. CONCLUSIONS: The increase in potentially problematic drinking levels among U.S. adults emphasizes the need for better prevention and treatment strategies. The study results support the validity of the WHO risk drinking levels, which show clinical utility as nonabstinent drinking reduction treatment goals. Such goals could engage more people in treatment, improving public health by decreasing personal and societal consequences of risk drinking.

来源:Am J Psychiatry,查看原文。版权归原作者所有。

引用

  1. Shmulewitz D, Aharonovich E, Witkiewitz K, et al. The World Health Organization Risk Drinking Levels Measure of Alcohol Consumption: Prevalence and Health Correlates in Nationally Representative Surveys of U.S. Adults, 2001-2002 and 2012-2013. Am J Psychiatry. 2021. PMID: 33472388. doi:10.1176/appi.ajp.2020.20050610

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。